The Unfolded Protein Response in Cancer The Unfolded Protein Response in Cancer
Cancer Drug Discovery and Development

The Unfolded Protein Response in Cancer

    • 87,99 €
    • 87,99 €

Publisher Description

This volume presents state-of-the-art information on each of the arms of the unfolded protein response (UPR), how their activation/repression are regulated, integrated, and coordinated, how UPR components affect cancer cell biology and responsiveness to therapeutic interventions, and how UPR components/activities offer potentially novel targets for drug discovery, repurposing, and development. The volume will provide the most recent information on the signaling and regulation of the UPR, explore examples of how the UPR and/or specific components contribute to cancer biology, and identify and explore specific examples of potently new actionable targets for drug discovery and development from within the UPR and its regulation.
Unique to the volume will be a specific focus on the UPR and its role in cancer biology, as well as a discussion of the role of the UPR in drug responses and resistance in cancer.

GENRE
Professional & Technical
RELEASED
2019
1 March
LANGUAGE
EN
English
LENGTH
231
Pages
PUBLISHER
Springer International Publishing
SIZE
10.9
MB

More Books by Robert Clarke

Cancer Systems and Integrative Biology Cancer Systems and Integrative Biology
2023
The Cambridge Companion to Postcolonial Travel Writing The Cambridge Companion to Postcolonial Travel Writing
2018
Les Enfants de la science Les Enfants de la science
1984
De l'univers à nous ou les Hasards de la vie De l'univers à nous ou les Hasards de la vie
1985
L'Homme mutant L'Homme mutant
1989
Travel Writing from Black Australia Travel Writing from Black Australia
2015

Other Books in This Series

Gene and Cellular Immunotherapy for Cancer Gene and Cellular Immunotherapy for Cancer
2022
Molecular Targeted Radiosensitizers Molecular Targeted Radiosensitizers
2020
Estrogen Receptor and Breast Cancer Estrogen Receptor and Breast Cancer
2018
Innovations for Next-Generation Antibody-Drug Conjugates Innovations for Next-Generation Antibody-Drug Conjugates
2018
Targeting the DNA Damage Response for Anti-Cancer Therapy Targeting the DNA Damage Response for Anti-Cancer Therapy
2018
Tumor Organoids Tumor Organoids
2017